Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Prescott

Showing results (221-230 of 299) with videos related to

Pageof 30
Sort By:
European Heart Journal|May 25, 2026
Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction populationAnna Meta Dyrvig Kristensen, Jarle Jortveit, Therese Holmager, et al.
International Archives of Occupational and Environmental Health|October 30, 2018
Prolonged or serious conflicts at work and incident dementia: a 23-year follow-up of the Copenhagen City Heart StudyKazi Ishtiak-Ahmed, Åse Marie Hansen, Erik Lykke Mortensen, et al.
European Heart Journal|March 26, 2026
Beta-blockers, depression, and anxiety after myocardial infarction: the BETAMI-DANBLOCK trialJohanne E Nyen, Anna Meta D Kristensen, Toril Dammen, et al.
Journal of the American Heart Association|April 13, 2016
Coronary Microvascular Function and Cardiovascular Risk Factors in Women With Angina Pectoris and No Obstructive Coronary Artery Disease: The iPOWER StudyNaja Dam Mygind, Marie Mide Michelsen, Adam Pena, et al.
International Journal of Cardiology|November 22, 2016
Transthoracic Doppler echocardiography compared with positron emission tomography for assessment of coronary microvascular dysfunction: The iPOWER studyMarie Mide Michelsen, Naja Dam Mygind, Adam Pena, et al.
ESC Heart Failure|March 23, 2021
Exercise training and high-sensitivity cardiac troponin T in patients with heart failure with reduced ejection fractionElias Koppen, Torbjørn Omland, Alf Inge Larsen, et al.
International Journal of Cardiology. Heart & Vasculature|February 25, 2026
Heart failure etiology and lipoprotein subfractions: Insight from the SMARTEX-HF studyTrine Karlsen, Elisabeth K Vesterbekkmo, Torstein Hole, et al.
International Journal of Cardiology|July 16, 2022
Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR studyEva Prescott, Oskar Angerås, David Erlinge, et al.
European Heart Journal|August 30, 2024
Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelinesWilliam E Boden, Raffaele De Caterina, Juan Carlos Kaski, et al.
Circulation|August 30, 2024
Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice GuidelinesWilliam E Boden, Raffaele De Caterina, Juan Carlos Kaski, et al.
Pageof 30

Showing results (221-230 of 299) with videos related to

Sort By:
Pageof 30
European Heart Journal|May 25, 2026
Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction populationAnna Meta Dyrvig Kristensen, Jarle Jortveit, Therese Holmager, et al.
International Archives of Occupational and Environmental Health|October 30, 2018
Prolonged or serious conflicts at work and incident dementia: a 23-year follow-up of the Copenhagen City Heart StudyKazi Ishtiak-Ahmed, Åse Marie Hansen, Erik Lykke Mortensen, et al.
European Heart Journal|March 26, 2026
Beta-blockers, depression, and anxiety after myocardial infarction: the BETAMI-DANBLOCK trialJohanne E Nyen, Anna Meta D Kristensen, Toril Dammen, et al.
Journal of the American Heart Association|April 13, 2016
Coronary Microvascular Function and Cardiovascular Risk Factors in Women With Angina Pectoris and No Obstructive Coronary Artery Disease: The iPOWER StudyNaja Dam Mygind, Marie Mide Michelsen, Adam Pena, et al.
International Journal of Cardiology|November 22, 2016
Transthoracic Doppler echocardiography compared with positron emission tomography for assessment of coronary microvascular dysfunction: The iPOWER studyMarie Mide Michelsen, Naja Dam Mygind, Adam Pena, et al.
ESC Heart Failure|March 23, 2021
Exercise training and high-sensitivity cardiac troponin T in patients with heart failure with reduced ejection fractionElias Koppen, Torbjørn Omland, Alf Inge Larsen, et al.
International Journal of Cardiology. Heart & Vasculature|February 25, 2026
Heart failure etiology and lipoprotein subfractions: Insight from the SMARTEX-HF studyTrine Karlsen, Elisabeth K Vesterbekkmo, Torstein Hole, et al.
International Journal of Cardiology|July 16, 2022
Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR studyEva Prescott, Oskar Angerås, David Erlinge, et al.
European Heart Journal|August 30, 2024
Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelinesWilliam E Boden, Raffaele De Caterina, Juan Carlos Kaski, et al.
Circulation|August 30, 2024
Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice GuidelinesWilliam E Boden, Raffaele De Caterina, Juan Carlos Kaski, et al.
Pageof 30